Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Buti

Showing results (281-290 of 387) with videos related to

Pageof 39
Sort By:
Journal of Hepatology|December 3, 2015
Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patientsW Ray Kim, Thomas Berg, Tarik Asselah, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|February 16, 2023
Economic Impact of European Liver and Intestine Transplantation Association (ELITA) Recommendations for Hepatitis B Prophylaxis After Liver TransplantationPaolo Angelo Cortesi, Raffaella Viganò, Sara Conti, et al.
International Journal of Emergency Medicine|January 4, 2024
Emergency department contribution to HCV elimination in the Iberian PeninsulaMaria Buti, Inês Vaz-Pinto, Vítor Magno Pereira, et al.
International Journal of Molecular Sciences|December 11, 2022
Quasispecies Fitness Partition to Characterize the Molecular Status of a Viral Population. Negative Effect of Early Ribavirin Discontinuation in a Chronically Infected HEV PatientJosep Gregori, Sergi Colomer-Castell, Carolina Campos, et al.
Hepatology (Baltimore, Md.)|November 21, 2017
Glecaprevir/Pibrentasvir in patients with hepatitis C virus genotype 1 or 4 and past direct-acting antiviral treatment failureFred Poordad, Stanislas Pol, Armen Asatryan, et al.
Journal of Clinical Microbiology|November 8, 2019
Significant Improvement in Diagnosis of Hepatitis C Virus Infection by a One-Step Strategy in a Central Laboratory: an Optimal Tool for Hepatitis C Elimination?Rosa López-Martínez, Andrea Arias-García, Francisco Rodríguez-Algarra, et al.
International Journal of Molecular Sciences|May 25, 2024
Genotyping Hepatitis B virus by Next-Generation Sequencing: Detection of Mixed Infections and Analysis of Sequence ConservationEva Dopico, Marta Vila, David Tabernero, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 19, 2026
No impact of low-dose nivolumab addition to JNJ-73763989 on HBsAg declines in chronic hepatitis B: the OCTOPUS-1 studyTarik Asselah, Scott K Fung, Sila Akhan, et al.
Journal of Hepatology|November 5, 2019
Glecaprevir/pibrentasvir for 8 weeks in treatment-naïve patients with chronic HCV genotypes 1-6 and compensated cirrhosis: The EXPEDITION-8 trialRobert S Brown, Maria Buti, Lino Rodrigues, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 17, 2025
Association of metabolic comorbidities with fibrosis severity and fibrosis regression in patients with chronic hepatitis BLisa M van Velsen, Lesley A Patmore, Jordan J Feld, et al.
Pageof 39

Showing results (281-290 of 387) with videos related to

Sort By:
Pageof 39
Journal of Hepatology|December 3, 2015
Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patientsW Ray Kim, Thomas Berg, Tarik Asselah, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|February 16, 2023
Economic Impact of European Liver and Intestine Transplantation Association (ELITA) Recommendations for Hepatitis B Prophylaxis After Liver TransplantationPaolo Angelo Cortesi, Raffaella Viganò, Sara Conti, et al.
International Journal of Emergency Medicine|January 4, 2024
Emergency department contribution to HCV elimination in the Iberian PeninsulaMaria Buti, Inês Vaz-Pinto, Vítor Magno Pereira, et al.
International Journal of Molecular Sciences|December 11, 2022
Quasispecies Fitness Partition to Characterize the Molecular Status of a Viral Population. Negative Effect of Early Ribavirin Discontinuation in a Chronically Infected HEV PatientJosep Gregori, Sergi Colomer-Castell, Carolina Campos, et al.
Hepatology (Baltimore, Md.)|November 21, 2017
Glecaprevir/Pibrentasvir in patients with hepatitis C virus genotype 1 or 4 and past direct-acting antiviral treatment failureFred Poordad, Stanislas Pol, Armen Asatryan, et al.
Journal of Clinical Microbiology|November 8, 2019
Significant Improvement in Diagnosis of Hepatitis C Virus Infection by a One-Step Strategy in a Central Laboratory: an Optimal Tool for Hepatitis C Elimination?Rosa López-Martínez, Andrea Arias-García, Francisco Rodríguez-Algarra, et al.
International Journal of Molecular Sciences|May 25, 2024
Genotyping Hepatitis B virus by Next-Generation Sequencing: Detection of Mixed Infections and Analysis of Sequence ConservationEva Dopico, Marta Vila, David Tabernero, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 19, 2026
No impact of low-dose nivolumab addition to JNJ-73763989 on HBsAg declines in chronic hepatitis B: the OCTOPUS-1 studyTarik Asselah, Scott K Fung, Sila Akhan, et al.
Journal of Hepatology|November 5, 2019
Glecaprevir/pibrentasvir for 8 weeks in treatment-naïve patients with chronic HCV genotypes 1-6 and compensated cirrhosis: The EXPEDITION-8 trialRobert S Brown, Maria Buti, Lino Rodrigues, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 17, 2025
Association of metabolic comorbidities with fibrosis severity and fibrosis regression in patients with chronic hepatitis BLisa M van Velsen, Lesley A Patmore, Jordan J Feld, et al.
Pageof 39